Your browser doesn't support javascript.
loading
Calprotectin as new potential clinical marker for multiple myeloma.
Khosravi, Parisa; Abroun, Saeid; Kaviani, Saeid; Masoudifar, Saman; Farahani, Homayoun Sarough.
Affiliation
  • Khosravi P; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Abroun S; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Kaviani S; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Masoudifar S; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Farahani HS; Arak university of Medical Science, Arak, Iran.
PLoS One ; 18(3): e0282841, 2023.
Article in En | MEDLINE | ID: mdl-36928900

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukocyte L1 Antigen Complex / Multiple Myeloma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2023 Document type: Article Affiliation country: Iran Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukocyte L1 Antigen Complex / Multiple Myeloma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2023 Document type: Article Affiliation country: Iran Country of publication: United States